Healthcare Equipment and Supplies
Company Overview of Miramar Labs, Inc.
Miramar Labs, Inc. develops medical devices for the treatment of dermatologic medical conditions. It offers miraDry System for the treatment of primary axillary hyperhidrosis and reducing underarm sweat; and miraWave technology, a technology platform that uses microwave energy for treatment in other medical areas, such as oncology, cardiology, and urology, as well as for dermatologic conditions. Miramar Labs, Inc. was formerly known as Foundry Newco X, Inc. The company was founded in 2006 and is based in Santa Clara, California.
2790 Walsh Avenue
Santa Clara, CA 95051
Founded in 2006
Key Executives for Miramar Labs, Inc.
Chief Executive Officer, President and Director
Co-Founder and Chairman of the Board
Chief Financial Officer and Senior Vice President
Vice President of Law and General Counsel
Managing Director for Asia Pacific
Compensation as of Fiscal Year 2015.
Miramar Labs, Inc. Key Developments
Miramar Labs' miraDry System Receives FDA Clearance
Jul 23 15
Miramar Labs announced its miraDry System received clearance from the U.S. Food & Drug Administration (FDA) for the treatment of unwanted underarm hair, and permanent reduction of underarm hair of all colors. This announcement establishes miraDry as the only technology FDA cleared for the treatment of underarm hair of all colors as well as the permanent reduction of underarm sweat. Miramar Lab's proprietary miraWave technology -use of precisely controlled microwave energy - is the foundation of the miraDry System. The permanent reduction of hair of all colors using miraWave is a significant technological advancement in the hair removal industry. Unlike laser hair removal systems, microwave energy doesn't require a chromophore to be effective and therefore can be used on hair of all colors, including light colored hair, and is also not limited by an individual's skin color. With this clearance, the company has announced the introduction of the miraSmooth treatment. The launch of miraSmooth is a perfect addition to plastic surgery and dermatology practices looking to offer their patients the latest in aesthetic procedures. miraSmooth will be made available in select markets beginning August of 2015.
Miramar Labs Announces Global Expansion of miraDry System into Chinese Market
Jul 16 15
Miramar Labs, Inc. announced that it has received State Food & Drug Administration (SFDA) approval for the marketing and sale of the miraDry® system in the People's Republic of China. The approval follows US Food and Drug Administration (FDA) clearance of miraDry in January 2011 and (CE) Mark approval in December 2013. The miraDry system utilizes the Company's proprietary miraWave™ technology and is the first system to permanently eliminate apocrine and eccrine glands in the axilla which are the cause of unwanted sweat and odor. The miraDry system is currently distributed in over forty  countries worldwide. The company reports over 40,000 miraDry treatments, and sweat reduction is one of the growing segments in aesthetics. With a population of over 1.4 billion people, expansion into China represents the growth opportunity for miraDry, as well as the aesthetic market, and the company is targeting very robust system sales in the first year alone.
Miramar Labs, Inc. Presents at Medical Device Conference 2015, Jun-26-2015 09:30 AM
Jun 22 15
Miramar Labs, Inc. Presents at Medical Device Conference 2015, Jun-26-2015 09:30 AM. Venue: Palace Hotel, 2 New Montgomery Street, San Francisco, California, United States. Speakers: Robert Michael Kleine, Chief Executive Officer, President and Director.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|